Literature DB >> 18481040

[Antidementia drugs--who has the benefit?].

M Gogol, H Förstl.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18481040     DOI： 10.1007/s00108-008-2160-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  3 in total

1.  [Antidementia drugs--response or non-response?].

Authors:  H Förstl
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

2.  [Patients with mild cognition impairment should not be treated with antidementia agents, except in studies].

Authors:  M Gogol
Journal:  Dtsch Med Wochenschr       Date:  2008-04       Impact factor: 0.628

3.  [Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].

Authors:  S Egert; S Wagenpfeil; H Förstl
Journal:  Dtsch Med Wochenschr       Date:  2007-06-01       Impact factor: 0.628
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.